ValiRx Plc (VAL) - Medical Equipment - Deals and Alliances Profile

Summary

ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The companys products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing of specific genes by targeted histone deacetylation for chromatin condensation. ValiRxs ValiMedix division sells and distributes oncology therapeutics. The companys ValiPharma division is a therapeutics division that provides technologies for the treatment of cancer. Itss ValiFinn division offers research and development services. The company also develops clinical trials, which is used to treat hormone induced refractory prostate cancer and other conditions of hormone. ValiRx is headquartered in London, the UK.

ValiRx Plc (VAL) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ValiRx Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ValiRx Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ValiRx Plc, Medical Equipment, Deal Details 10
Asset Purchase 10
ValiRx Acquires Biomarkers Business Unit From Pharmatest Services For US$0.2 Million 10
Equity Offering 12
ValiRx Raises USD1.5 Million in Private Placement of Shares 12
ValiRx Raises USD1.33 Million in Private Placement of Shares 13
ValiRx Raises USD0.05 Million in Private Placement of Shares up on Exercise of Warrants 14
ValiRx Raises USD0.1 Million in Private Placement of Shares up on Exercise of Warrants 15
ValiRx Raises USD0.7 Million in Private Placement of Shares 16
Valirx Raises Funds in Private Placement of Shares 17
Valirx Raises USD1.4 Million in Private Placement of Shares 18
Valirx Raises USD1.58 Million in Placing of Ordinary Shares 19
Acquisition 20
ValiRx Divests Its Stake In VolitionRx For US$0.6 Million 20
ValiRx Plc - Key Competitors 21
ValiRx Plc - Key Employees 22
ValiRx Plc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 23
Recent Developments 24
Financial Announcements 24
Sep 25, 2018: VALIRX: Half yearly report for the period ended 30 June 2018 24
Apr 10, 2018: ValiRx: Final Results for the Year Ended 31 December 2017 26
Sep 26, 2017: Valirx: Half Yearly Report For The Period Ended 30 June 2017 30
May 05, 2017: ValiRx: Final Results for the Year Ended 31 December 2016 32
Legal and Regulatory 35
Apr 18, 2017: ValiRx: Change of Registered Office 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables


ValiRx Plc, Medical Equipment, Key Facts, 2017 2
ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ValiRx Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ValiRx Plc, Deals By Market, 2012 to YTD 2018 8
ValiRx Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ValiRx Acquires Biomarkers Business Unit From Pharmatest Services For US$0.2 Million 10
ValiRx Raises USD1.5 Million in Private Placement of Shares 12
ValiRx Raises USD1.33 Million in Private Placement of Shares 13
ValiRx Raises USD0.05 Million in Private Placement of Shares up on Exercise of Warrants 14
ValiRx Raises USD0.1 Million in Private Placement of Shares up on Exercise of Warrants 15
ValiRx Raises USD0.7 Million in Private Placement of Shares 16
Valirx Raises Funds in Private Placement of Shares 17
Valirx Raises USD1.4 Million in Private Placement of Shares 18
Valirx Raises USD1.58 Million in Placing of Ordinary Shares 19
ValiRx Divests Its Stake In VolitionRx For US$0.6 Million 20
ValiRx Plc, Key Competitors 21
ValiRx Plc, Key Employees 22
ValiRx Plc, Subsidiaries 23
ValiRx Plc, Joint Venture 23

List Of Figures


ValiRx Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ValiRx Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ValiRx Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ValiRx Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ValiRx Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

ValiRx Plc (VAL) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The companys products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE BCL-2, and

USD 250 View Report

VALIRX PLC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

VALIRX PLC Company Profile is a detailed strategic and analytical report on VALIRX PLC. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Valaris Plc (VAL) - Financial and Strategic SWOT Analysis Review

Valaris Plc (VAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

ValiRx Plc (VAL) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The companys products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE BCL-2, and

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available